MYCEA at CIMA 2025 New biocontrol solutions from forest fungal extracts
On December 4th, MYCEA presented its scientific advances at the 14th International Conference on Plant Diseases (CIMA) in Angers. Organized by Végéphyl, this conference brings together researchers, technical institutes, and industry players. The 2025 edition placed plant protection against diseases at the heart of discussions in the context of agroecological transition.
A unique extract library and platform approach
MYCEA develops biocontrol solutions derived from forest fungi. Our approach is based on a proprietary collection of over 750 forest fungal strains, systematically screened for their potential against crop diseases.
“Our method consists of screening, comparing, and prioritizing the most promising extracts according to strict criteria of efficacy, safety, and industrial viability,” explains Dominique Barry-Etienne, Science & Production CEO and co-founder of MYCEA.
A rigorous selection process
Our development pipeline follows a structured methodology:
- Initial validation: confirmation of mycelial extract efficacy in the laboratory
- Production: development of scalable liquid bio-production processes in bioreactors
- Characterization: identification and purification of active substances
Each phase integrates toxicological and ecotoxicological assessments aligned with OECD standards, enabling rapid identification of the most promising candidates.
Grapevine and potato downy mildew
After two years of plant and field trials with Contract Research Organizations (CROs), our lead candidate demonstrates very promising preventive efficacy against grapevine downy mildew (P. viticola) and potato late blight (P. infestans).
These results were obtained with documented dose-response data and rigorous comparison against untreated controls and standard references.
The solution against downy mildew may already be beneath our feet, in forest ecosystems.
